Lariciresinol
Product Specifications
CAS Number
27003-73-2
Target
TGF-beta/Smad, glycosidase, Antifection, Antifungal, Apoptosis, Bcl-2 Family, NF-κB, VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Metabolism, Microbiology/Virology, Apoptosis, Stem Cells, Angiogenesis, NF-κB
Purity
0.9984
Bioactivity
Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
Smiles
C(O)[C@@H]1[C@H](OC[C@@H]1CC2=CC(OC)=C(O)C=C2)C3=CC(OC)=C(O)C=C3
Molecular Formula
C20H24O6
Molecular Weight
360.4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TMAC-01005-01 50 μL
Anti-Phospho-CtBP1 (Ser422) Polyclonal Antibody
Sign In for Pricing
View Details TMAC-01005-02 100 µL
Anti-Phospho-CtBP1 (Ser422) Polyclonal Antibody
Sign In for Pricing
View Details MBS1323711-01 0.02 mg (E-Coli)
Recombinant Caenorhabditis elegans Putative RNA polymerase II transcriptional coactivator (T13F2.2)
Sign In for Pricing
View Details MBS1323711-02 0.1 mg (E-Coli)
Recombinant Caenorhabditis elegans Putative RNA polymerase II transcriptional coactivator (T13F2.2)
Sign In for Pricing
View Details